Effects of Aryl Hydrocarbon Receptor Deficiency on PCB-77-Induced Impairment of Glucose Homeostasis during Weight Loss in Male and Female Obese Mice.


Journal

Environmental health perspectives
ISSN: 1552-9924
Titre abrégé: Environ Health Perspect
Pays: United States
ID NLM: 0330411

Informations de publication

Date de publication:
07 2019
Historique:
entrez: 16 7 2019
pubmed: 16 7 2019
medline: 13 3 2020
Statut: ppublish

Résumé

Lipophilic polychlorinated biphenyls (PCBs) accumulate with obesity, but during weight loss, liberated PCBs act as ligands of the aryl hydrocarbon receptor (AhR) to negatively influence health. Previous studies demonstrated that PCB-77 administration to obese male mice impaired glucose tolerance during weight loss. Recent studies indicate higher toxic equivalencies of dioxin-like PCBs in exposed females than males. We compared effects of PCB-77 on weight gain or loss and glucose homeostasis in male vs. female mice. We defined effects of AhR deficiency during weight gain or loss in male and female mice exposed to PCB-77. Study design was vehicle (VEH) or PCB-77 administration while fed a high-fat (HF) diet for 12 wk, followed by weight loss for 4 wk. The following groups were examined: male and female C57BL/6 mice administered VEH or PCB-77, female [Formula: see text] and [Formula: see text] mice administered VEH or PCB-77, and male [Formula: see text] and [Formula: see text] mice administered PCB-77. Glucose tolerance was quantified during weight gain (week 11) and loss (week 15); liver and adipose AhR and IRS2 (insulin receptor substrate 2) mRNA abundance, and PCB-77 concentrations were quantified at week 16. PCB-77 attenuated development of obesity in females but not males. During weight loss, PCB-77 impaired glucose tolerance of males. AhR-deficient females (VEH) were resistant to diet-induced obesity. Compared with VEH-treated mice, HF-fed [Formula: see text] females treated with PCB-77 has less weight gain, and [Formula: see text] females had greater weight gain. During weight loss, [Formula: see text] females but not [Formula: see text] males treated with PCB-77 exhibited impaired glucose tolerance. In [Formula: see text] females administered PCB-77, IRS2 mRNA abundance was lower in adipose tissue compared with VEH-treated mice. Male and female mice responded differently to PCB-77 and AhR deficiency in body weight (BW) regulation and glucose homeostasis. AhR deficiency reversed PCB-77-induced glucose impairment of obese males losing weight but augmented glucose intolerance of females. These results demonstrate sex differences in PCB-77-induced regulation of glucose homeostasis of mice. https://doi.org/10.1289/EHP4133.

Sections du résumé

BACKGROUND
Lipophilic polychlorinated biphenyls (PCBs) accumulate with obesity, but during weight loss, liberated PCBs act as ligands of the aryl hydrocarbon receptor (AhR) to negatively influence health. Previous studies demonstrated that PCB-77 administration to obese male mice impaired glucose tolerance during weight loss. Recent studies indicate higher toxic equivalencies of dioxin-like PCBs in exposed females than males.
OBJECTIVES
We compared effects of PCB-77 on weight gain or loss and glucose homeostasis in male vs. female mice. We defined effects of AhR deficiency during weight gain or loss in male and female mice exposed to PCB-77.
METHODS
Study design was vehicle (VEH) or PCB-77 administration while fed a high-fat (HF) diet for 12 wk, followed by weight loss for 4 wk. The following groups were examined: male and female C57BL/6 mice administered VEH or PCB-77, female [Formula: see text] and [Formula: see text] mice administered VEH or PCB-77, and male [Formula: see text] and [Formula: see text] mice administered PCB-77. Glucose tolerance was quantified during weight gain (week 11) and loss (week 15); liver and adipose AhR and IRS2 (insulin receptor substrate 2) mRNA abundance, and PCB-77 concentrations were quantified at week 16.
RESULTS
PCB-77 attenuated development of obesity in females but not males. During weight loss, PCB-77 impaired glucose tolerance of males. AhR-deficient females (VEH) were resistant to diet-induced obesity. Compared with VEH-treated mice, HF-fed [Formula: see text] females treated with PCB-77 has less weight gain, and [Formula: see text] females had greater weight gain. During weight loss, [Formula: see text] females but not [Formula: see text] males treated with PCB-77 exhibited impaired glucose tolerance. In [Formula: see text] females administered PCB-77, IRS2 mRNA abundance was lower in adipose tissue compared with VEH-treated mice.
CONCLUSION
Male and female mice responded differently to PCB-77 and AhR deficiency in body weight (BW) regulation and glucose homeostasis. AhR deficiency reversed PCB-77-induced glucose impairment of obese males losing weight but augmented glucose intolerance of females. These results demonstrate sex differences in PCB-77-induced regulation of glucose homeostasis of mice. https://doi.org/10.1289/EHP4133.

Identifiants

pubmed: 31306034
doi: 10.1289/EHP4133
pmc: PMC6794491
doi:

Substances chimiques

Ahr protein, mouse 0
Basic Helix-Loop-Helix Transcription Factors 0
Receptors, Aryl Hydrocarbon 0
Polychlorinated Biphenyls DFC2HB4I0K
Glucose IY9XDZ35W2
3,4,3',4'-tetrachlorobiphenyl Y2I6546TMI

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

77004

Subventions

Organisme : NIH HHS
ID : S10 OD021753
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES026529
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM127211
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007778
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES007380
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103527
Pays : United States
Organisme : NCRR NIH HHS
ID : P20 RR021954
Pays : United States

Références

Compr Physiol. 2017 Sep 12;7(4):1085-1135
pubmed: 28915320
Int J Obes Relat Metab Disord. 2000 Oct;24(10):1272-8
pubmed: 11093288
Pharmacol Toxicol. 1993 Jul;73(1):52-6
pubmed: 8234194
BMC Genomics. 2015 Aug 20;16:625
pubmed: 26290441
Toxicol Appl Pharmacol. 2012 Jul 15;262(2):167-76
pubmed: 22564538
J Pediatr Gastroenterol Nutr. 2000 Feb;30(2):164-9
pubmed: 10697135
Toxicology. 2001 Feb 14;158(3):141-53
pubmed: 11275356
Sci Total Environ. 2015 Nov 15;533:144-55
pubmed: 26151658
Environ Res. 2014 Aug;133:170-7
pubmed: 24949816
Bull Environ Contam Toxicol. 1981 Jul;27(1):23-7
pubmed: 7296033
Arch Environ Contam Toxicol. 2008 Jul;55(1):143-52
pubmed: 18166985
Environ Health Perspect. 2011 Mar;119(3):377-83
pubmed: 21156398
Obes Rev. 2014 Jan;15(1):19-28
pubmed: 23998203
Toxicol Sci. 2016 Jan;149(1):98-110
pubmed: 26396156
Environ Health Perspect. 2012 May;120(5):727-32
pubmed: 22334129
Nutr Res. 2017 Aug;44:38-50
pubmed: 28821316
Environ Health Perspect. 2008 Jun;116(6):761-8
pubmed: 18560532
Toxicol Appl Pharmacol. 2015 Apr 15;284(2):188-96
pubmed: 25703434
Pediatr Res. 1998 Aug;44(2):222-5
pubmed: 9702918
Bull Environ Contam Toxicol. 1998 Nov;61(5):557-68
pubmed: 9841714
JAMA. 2016 Jun 7;315(21):2284-91
pubmed: 27272580
Diabetologia. 2012 Oct;55(10):2565-2582
pubmed: 22869320
Toxicol Sci. 2016 Aug;152(2):340-8
pubmed: 27208082
Diabetes Care. 2011 Sep;34(9):1972-9
pubmed: 21816981
Toxicology. 2016 Apr 29;355-356:9-20
pubmed: 27163630
BMC Clin Pharmacol. 2010 Jan 07;10:1
pubmed: 20055995
Toxicol Appl Pharmacol. 1998 Dec;153(2):199-210
pubmed: 9878591
Nature. 2003 May 29;423(6939):545-50
pubmed: 12774124
Bull Environ Contam Toxicol. 1994 Mar;52(3):400-3
pubmed: 8142711
J Biol Chem. 2000 Dec 15;275(50):38990-4
pubmed: 10995761
Environ Sci Pollut Res Int. 2016 Feb;23(3):2201-11
pubmed: 25586614
Environ Toxicol Pharmacol. 2008 Mar;25(2):251-9
pubmed: 18438459
J Toxicol Environ Health A. 1998 Feb 20;53(4):293-311
pubmed: 9490327
PLoS One. 2017 Sep 18;12(9):e0184842
pubmed: 28922406
Environ Health Perspect. 2010 Sep;118(9):1235-42
pubmed: 20444671
Toxicology. 2017 Sep 1;390:43-52
pubmed: 28774668
Int J Obes (Lond). 2011 May;35(5):744-7
pubmed: 20820170
Diabetes Care. 2011 Aug;34(8):1778-84
pubmed: 21700918
Toxicol Sci. 2002 Dec;70(2):171-82
pubmed: 12441362
Environ Res. 2013 Apr;122:31-7
pubmed: 23290489
Environ Health Perspect. 2015 Oct;123(10):944-50
pubmed: 25734695
Environ Health Perspect. 2013 Jan;121(1):105-10
pubmed: 23099484
Chemosphere. 2009 Jan;74(3):384-8
pubmed: 19004467
Obesity (Silver Spring). 2011 Apr;19(4):709-14
pubmed: 20559302
Toxicol Sci. 2016 Feb;149(2):396-410
pubmed: 26612838
Mol Cell Biol. 2013 Aug;33(15):2817-28
pubmed: 23689136
Environ Health Perspect. 2012 Apr;120(4):508-14
pubmed: 22262711
Sci Total Environ. 2018 Oct 1;637-638:881-891
pubmed: 29763869

Auteurs

Erin N Jackson (EN)

Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Sean E Thatcher (SE)

Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Nika Larian (N)

Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Victoria English (V)

Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Sony Soman (S)

Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA.

Andrew J Morris (AJ)

Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA.

Jiaying Weng (J)

Department of Statistics, University of Kentucky, Lexington, Kentucky, USA.

Arnold Stromberg (A)

Department of Statistics, University of Kentucky, Lexington, Kentucky, USA.

Hollie I Swanson (HI)

Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Kevin Pearson (K)

Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Lisa A Cassis (LA)

Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, Kentucky, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH